Teradata today announced details about its new AI Services, addressing a critical enterprise challenge: transforming AI pilots into production-ready agentic solutions that deliver significant business ...
United by a shared mission to bring the many benefits of music to the community, the Orchestre symphonique de Montréal and Médecins francophones du Canada are joining forces to launch a new initiative ...
Opinion

The Age of De-Skilling

But the real puzzle isn’t whether de-skilling exists—it plainly does—but rather what kind of thing it is. Are all forms of de-skilling corrosive? Or are there kinds that we can live with, that might ...
NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immune checkpoint mechanism distinct from PD-1/PD-L1 therapies NX-1607 ...
Please provide your email address to receive an email when new articles are posted on . In our journey through academia, contract research organizations, big pharma and biotech startups, we have had ...
Regeneron has posted updated clinical data on DB-OTO, providing more evidence of the gene therapy’s potential to treat a rare genetic form of deafness as it plans for a potential FDA filing later this ...
Wilkes University is now the defendant in a class-action lawsuit over a data breach that allegedly compromised the sensitive information of over 27,000 people. “This class action arises from (the) ...
SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/ -- A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake (NASDAQ: ...
Humana and Providence on Monday unveiled a new data exchange partnership the major payer and provider said could become a blueprint for the broader industry. The data sharing ecosystem is slated to go ...
Misdiagnosis or underdiagnosis of rare diseases in patients with diagnoses of common diseases can lead to delayed or inappropriate treatments, thereby complicating the management of both rare and ...